BioNexus Gene Lab

Ruanyun Edai Technology has announced a definitive agreement to license its Cogni AI platform to BioNexus Gene Lab for use in Malaysia's healthcare market. The deal would place the AI technology into Malaysian medical settings through BioNexus Gene Lab's operations. Details on the financial terms and timeline of the agreement have not been disclosed, and reaction to the announcement remains limited so far.